Pore et al. demonstrated decreased expression of VEGF in head and neck squamous cell carcinoma, lung cancer and glioblastoma cells in response to nelfinavir, which was associated with reduced angiogenesis in vivo [103,104]. Here, VEGFA is linked to lung carcinoma.